新型G蛋白偶联受体X2在皮肤科的研究进展

doi:10.35541/cjd.20240124

Abstract

Abstract: 【Abstract】 Mast cells play a role in allergic reactions by secreting a variety of inflammatory mediators. The classical pathway of mast cell activation is mediated by high-affinity IgE receptors. In recent years, the Mas-related G protein-coupled receptor X2 （MRGPRX2） has been identified as the receptor responsible for non-IgE mediated mast cell activation. This review mainly summarizes the research progress in the role of the MRGPRX2 receptor in chronic urticaria, atopic dermatitis, allergic contact dermatitis, pseudoallergic reactions, rosacea, and other skin diseases.

Key words: G-protein-coupled receptor kinases, Mast cells, Urticaria, Dermatitis, atopic, Dermatitis, allergic contact, MRGPRX2, Rosacea, Pseudoallergic drug reaction

He Xingyan, Zhang Kejia, Feng Yanyan. Noval G protein-coupled receptor X2 in dermatology[J]. Chinese Journal of Dermatology,2024,e20240124. doi:10.35541/cjd.20240124

References ［32］

［1］	Kumar M, Duraisamy K, Chow BK. Unlocking the non⁃IgE⁃mediated pseudo⁃allergic reaction puzzle with Mas⁃related G⁃protein coupled receptor member X2 （MRGPRX2）［J］. Cells, 2021,10（5）:1033. doi: 10.3390/cells10051033.
［2］	Young D, Waitches G, Birchmeier C, et al. Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains［J］. Cell, 1986,45（5）:711⁃719. doi: 10.1016/0092⁃8674（86）90785⁃3.
［3］	Inclan⁃Rico JM, Kim BS, Abdus⁃Saboor I. Beyond somatosensation: Mrgprs in mucosal tissues［J］. Neurosci Lett, 2021,748:135689. doi: 10.1016/j.neulet.2021.135689.
［4］	Wang Z, Franke K, Bal G, et al. MRGPRX2⁃mediated degranulation of human skin mast cells requires the operation of G（αi）, G（αq）, Ca++ channels, ERK1/2 and PI3K⁃interconnection between early and late signaling［J］. Cells, 2022,11（6）:953. doi: 10.3390/cells11060953.
［5］	Babina M, Wang Z, Roy S, et al. MRGPRX2 is the codeine receptor of human skin mast cells: desensitization through β⁃arrestin and lack of correlation with the FcεRⅠ pathway［J］. J Invest Dermatol, 2021,141（5）:1286⁃1296. doi: 10.1016/j.jid. 2020.09.017.
［6］	Chompunud Na Ayudhya C, Amponnawarat A, Ali H. Substance P serves as a balanced agonist for MRGPRX2 and a single tyrosine residue is required for β⁃arrestin recruitment and receptor internalization［J］. Int J Mol Sci, 2021,22（10）:5318. doi: 10.3390/ijms22105318.
［7］	Che D, Zheng Y, Hou Y, et al. Action of substance P and PAMP（9⁃20） on different excitation sites of MRGPRX2 induces differences in mast cell activation［J］. Int Immunopharmacol, 2021,101（Pt B）:108342. doi: 10.1016/j.intimp.2021.108342.
［8］	Ogasawara H, Noguchi M. Therapeutic potential of MRGPRX2 inhibitors on mast cells［J］. Cells, 2021,10（11）:2906. doi: 10. 3390/cells10112906.
［9］	Fujisawa D, Kashiwakura J, Kita H, et al. Expression of Mas⁃related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria［J］. J Allergy Clin Immunol, 2014,134（3）:622⁃633.e9. doi: 10.1016/j.jaci.2014.05.004.
［10］	Fadaee J, Khoshkhui M, Emadzadeh M, et al. Evaluation of serum substance P level in chronic urticaria and correlation with disease severity［J］. Iran J Allergy Asthma Immunol, 2020,19（1）:18⁃26. doi: 10.18502/ijaai.v19i1.2414.
［11］	Cao T, Cha HY, Yang EM, et al. Elevated MRGPRX2 levels related to disease severity in patients with chronic spontaneous urticaria［J］. Allergy Asthma Immunol Res, 2021,13（3）:498⁃506. doi: 10.4168/aair.2021.13.3.498.
［12］	Shtessel M, Limjunyawong N, Oliver ET, et al. MRGPRX2 activation causes increased skin reactivity in patients with chronic spontaneous urticaria［J］. J Invest Dermatol, 2021,141（3）:678⁃681.e2. doi: 10.1016/j.jid.2020.06.030.
［13］	Nishimori N, Toyoshima S, Sasaki⁃Sakamoto T, et al. Serum level of hemokinin⁃1 is significantly lower in patients with chronic spontaneous urticaria than in healthy subjects［J］. Allergol Int, 2021,70（4）:480⁃488. doi: 10.1016/j.alit.2021.05.002.
［14］	Wang Z, Babina M. MRGPRX2 signals its importance in cutaneous mast cell biology: does MRGPRX2 connect mast cells and atopic dermatitis?［J］. Exp Dermatol, 2020,29（11）:1104⁃1111. doi: 10.1111/exd.14182.
［15］	Serhan N, Basso L, Sibilano R, et al. House dust mites activate nociceptor⁃mast cell clusters to drive type 2 skin inflammation［J］. Nat Immunol, 2019,20（11）:1435⁃1443. doi: 10.1038/s41590⁃019⁃0493⁃z.
［16］	Babina M, Wang Z, Franke K, et al. Thymic stromal lymphopoietin promotes MRGPRX2⁃triggered degranulation of skin mast cells in a STAT5⁃dependent manner with further support from JNK［J］. Cells, 2021,10（1）:102. doi: 10.3390/cells10010102.
［17］	Jia T, Che D, Zheng Y, et al. Mast cells initiate type 2 inflammation through tryptase released by MRGPRX2/MRGPRB2 activation in atopic dermatitis［J］. J Invest Dermatol, 2024,144（1）:53⁃62.e2. doi: 10.1016/j.jid.2023.06.201.
［18］	Redhu D, Franke K, Aparicio⁃Soto M, et al. Mast cells instruct keratinocytes to produce thymic stromal lymphopoietin: relevance of the tryptase/protease⁃activated receptor 2 axis［J］. J Allergy Clin Immunol, 2022,149（6）:2053⁃2061.e6. doi: 10.1016/j.jaci.2022.01.029.
［19］	Meixiong J, Anderson M, Limjunyawong N, et al. Activation of mast⁃cell⁃expressed Mas⁃related G⁃protein⁃coupled receptors drives non⁃histaminergic itch［J］. Immunity, 2019,50（5）:1163⁃1171.e5. doi: 10.1016/j.immuni.2019.03.013.
［20］	Larsen EG, Cho TS, McBride ML, et al. Transmembrane protein TMEM184B is necessary for interleukin⁃31⁃induced itch［J］. Pain, 2022,163（5）:e642⁃e653. doi: 10.1097/j.pain.00000000 00002452.
［21］	Yoshida K, Tanihara S, Miyashita Y, et al. P2X4 receptor stimulation enhances MrgprB2⁃mediated mast cell activation and pseudoallergic reactions in mice［J］. Sci Rep, 2022,12（1）:18613. doi: 10.1038/s41598⁃022⁃21667⁃6.
［22］	Suzuki Y, Liu S, Kadoya F, et al. Association between mutated Mas⁃related G⁃protein⁃coupled receptor⁃X2 and rocuronium⁃induced intraoperative anaphylaxis. Comment on Br J Anaesth 2020; 125: e448⁃50［J］. Br J Anaesth, 2021,127（1）:e21⁃e22. doi: 10.1016/j.bja.2021.04.009.
［23］	Chompunud Na Ayudhya C, Amponnawarat A, Roy S, et al. MRGPRX2 activation by rocuronium: insights from studies with human skin mast cells and missense variants［J］. Cells, 2021,10（1）:156. doi: 10.3390/cells10010156.
［24］	McNeil BD, Pundir P, Meeker S, et al. Identification of a mast⁃cell⁃specific receptor crucial for pseudo⁃allergic drug reactions［J］. Nature, 2015,519（7542）:237⁃241. doi: 10.1038/nature14022.
［25］	中华医学会皮肤性病学分会玫瑰痤疮研究中心, 中国医师协会皮肤科医师分会玫瑰痤疮专业委员会. 中国玫瑰痤疮诊疗指南（2021版）［J］. 中华皮肤科杂志, 2021,54（4）:279⁃288. doi: 10.35541/cjd.20201078.
［26］	Chen C, Wang P, Zhang L, et al. Exploring the pathogenesis and mechanism⁃targeted treatments of rosacea: previous understanding and updates［J］. Biomedicines, 2023,11（8）:2153. doi: 10.3390/biomedicines11082153.
［27］	Roy S, Alkanfari I, Chaki S, et al. Role of MrgprB2 in rosacea⁃like inflammation in mice: modulation by β⁃arrestin 2［J］. J Invest Dermatol, 2022,142（11）:2988⁃2997.e3. doi: 10.1016/j.jid.2022.05.005.
［28］	Marek⁃Jozefowicz L, Nedoszytko B, Grochocka M, et al. Molecular mechanisms of neurogenic inflammation of the skin［J］. Int J Mol Sci, 2023,24（5）:5001. doi: 10.3390/ijms2405 5001.
［29］	Azimi E, Reddy VB, Shade KC, et al. Dual action of neurokinin⁃1 antagonists on Mas⁃related GPCRs［J］. JCI Insight, 2016,1（16）:e89362. doi: 10.1172/jci.insight.89362.
［30］	Wang J, Zhang Y, Hu S, et al. Resveratrol inhibits MRGPRX2⁃mediated mast cell activation via Nrf2 pathway［J］. Int Immunopharmacol, 2021,93:107426. doi: 10.1016/j.intimp.2021. 107426.
［31］	Xue Z, Zhang Y, Zeng Y, et al. Licochalcone A inhibits MAS⁃related GPR family member X2⁃induced pseudo⁃allergic reaction by suppressing nuclear migration of nuclear factor⁃κB［J］. Phytother Res, 2021,35（11）:6270⁃6280. doi: 10.1002/ptr.7272.
［32］	Syed M, Kammala AK, Callahan B, et al. Lactic acid suppresses MRGPRX2 mediated mast cell responses［J］. Cell Immunol, 2021,368:104422. doi: 10.1016/j.cellimm.2021.104422.

[1]	Chinese Society of Dermatology, China Dermatologist Association, Combination of Traditional and Western Medicine Dermatology, Chinese Non-Government Dermatologist Institutions Association. Expert consensus on educational guidance for rosacea patients（2025） [J]. Chinese Journal of Dermatology, 2026, 0(1): 20240725-e20240725.
[2]	Song Pu, Liu Yu, Guo Sen, Li Shuli, Liu Ling, Li Chunying. Mast cell-derived chemokine C-C motif ligand 5 affects the migration of CD8+ T cells from vitiligo patients under oxidative stress [J]. Chinese Journal of Dermatology, 2025, 58(9): 839-843.
[3]	Zheng Yaxuan, Su Huichun. Role of sweat in the pathogenesis of cholinergic urticaria [J]. Chinese Journal of Dermatology, 2025, 58(6): 573-577.
[4]	Qi-Quan CHEN Song Zhi-Qiang WANG Gang. Guidelines for the diagnosis and treatment of refractory chronic spontaneous urticaria in China （2025 edition） [J]. Chinese Journal of Dermatology, 2025, 58(6): 485-496.
[5]	Tang Huiyang, Yang Zhi, Yang Xi, Yao Zhengqiu, Hao Fei, Chen Bangtao. Mechanistic studies on the involvement of trimethylamine oxide in the pathogenesis of chronic spontaneous urticaria [J]. Chinese Journal of Dermatology, 2025, 58(6): 515-522.
[6]	Huang Xuewei, Chen Qiquan, Yang Xianjie, Chen Anqi, Wang Huan, Deng Sisi, Zhai Zhifang, Wang Juan, Song Zhiqiang . Comparisons of clinical and pathological characteristics of urticarial vasculitis versus chronic spontaneous urticaria with pigmentation [J]. Chinese Journal of Dermatology, 2025, 58(6): 508-514.
[7]	Xiao Meng, Zhao Meiru, Zhang Xinmei, Zhang Junyan, Qi Yuqing, Wang Huiping. Disease burden in patients with chronic spontaneous urticaria: a single-center retrospective analysis [J]. Chinese Journal of Dermatology, 2025, 58(6): 530-535.
[8]	Liang Bihua, Chen Ziyan, Li Huaping, Zou Hui, Lin Tianyi, Li Xiaofeng, Zhang Luoyu, Li Shengxin, Ou Shanshan, Chen Jiaoquan, Li Runxiang, Zhu Huilan. Analysis of serum inflammatory factors associated with antihistamine resistance in patients with chronic spontaneous urticaria using the Olink-targeted proteomics technology [J]. Chinese Journal of Dermatology, 2025, 58(6): 523-529.
[9]	Zhao Meiru, Xiao Meng, Zhang Xinmei, Zhang Junyan, Qi Yuqing, Wang Huiping. Omalizumab for the treatment of eight patients with chronic spontaneous urticaria during pregnancy and lactation [J]. Chinese Journal of Dermatology, 2025, 58(6): 536-539.
[10]	He Zezhi, Chen Jiazhen, Wu Hui, Shen Haojia, Zhu Huilan, Li Runxiang. Trends in urticaria incidence and its association with air pollutants among children aged 0 - 14 years in China from 1990 to 2021: a multi-model analysis [J]. Chinese Journal of Dermatology, 2025, 58(6): 540-545.
[11]	Qiu Li, Xiao Ting . Bruton′s tyrosine kinase inhibitors in the treatment of chronic spontaneous urticaria [J]. Chinese Journal of Dermatology, 2025, 58(6): 563-567.
[12]	Liang Gaopeng, Yang Xianjie, Chen Qiquan, Song Zhiqiang. Comorbidities of chronic urticaria [J]. Chinese Journal of Dermatology, 2025, 58(6): 567-572.
[13]	Song Zhiqiang, Yang Xianjie, Chen Qiquan. Disease management and modification in chronic spontaneous urticaria: needs and prospects in the new era [J]. Chinese Journal of Dermatology, 2025, 58(6): 503-507.
[14]	Li Enze, Chen Lu, Zhang Chuqiao, Yao Yuxu, Jiao Qingqing, Ji Jiang. Correlations of gut microbiota and short-chain fatty acids with chronic spontaneous urticaria [J]. Chinese Journal of Dermatology, 2025, 58(6): 577-581.
[15]	Lianghong Chen Yan SUN Jing-Yu WANG. Benvitimod for the treatment of dermatoses [J]. Chinese Journal of Dermatology, 2025, 58(3): 266-268.

Noval G protein-coupled receptor X2 in dermatology

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［32］

Related Articles 15

Metrics

Comments

Recommended 10